Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;125(10):e30645.
doi: 10.1002/jcb.30645. Epub 2024 Sep 20.

Mechanisms of Sigma-2/TMEM97 Involvement in Cholesterol Metabolism

Affiliations

Mechanisms of Sigma-2/TMEM97 Involvement in Cholesterol Metabolism

Martina Parente et al. J Cell Biochem. 2024 Oct.

Abstract

Extensive research has focused on cellular cholesterol and its regulation, primarily due to its crucial physiological roles and its association with numerous diseases resulting from dysregulated homeostasis. Consequently, investigating cholesterol metabolism and the network of regulating proteins remains an ongoing challenge for biomedical research seeking new molecular targets to manage aberrant cholesterol levels in pathologic conditions. There is evidence that Sigma-2/TMEM97 receptor regulates cholesterol metabolism. However, the mechanisms remain incompletely understood to date. Therefore, this study aimed to employ a pharmacological approach based on selective Sigma-2/TMEM97 agonists, rimcazole and siramesine, to uncover the contribution of this receptor to cholesterol homeostasis. Our results indicate that Sigma-2/TMEM97 activation modulates cholesterol uptake by altering key proteins involved in, leading to free cholesterol and neutral lipids accumulation. This sheds light on potential mechanisms implied, contributing a new piece to the intricate puzzle of cholesterol metabolism homeostasis.

Keywords: HepG2; Sigma‐2/TMEM97; cholesterol; lipid metabolism; lysosome; rimcazole; siramesine.

PubMed Disclaimer

References

    1. W. Y. Ho, H. Hartmann, and S.‐C. Ling, “Central Nervous System Cholesterol Metabolism in Health and Disease,” IUBMB Life 74, no. 8 (2022): 826–841, https://doi.org/10.1002/iub.2662.
    1. C. Martini and V. Pallottini, “Cholesterol: From Feeding to Gene Regulation,” Genes & Nutrition 2, no. 2 (2007): 181–193, https://doi.org/10.1007/s12263-007-0049-y.
    1. F. W. Pfrieger and N. Ungerer, “Cholesterol Metabolism in Neurons and Astrocytes,” Progress in Lipid Research 50, no. 4 (2011): 357–371, https://doi.org/10.1016/j.plipres.2011.06.002.
    1. F. W. Pfrieger, “Role of Cholesterol in Synapse Formation and Function,” Biochimica et Biophysica Acta (BBA)—Biomembranes 1610, no. 2 (2003): 271–280, https://doi.org/10.1016/s0005-2736(03)00024-5.
    1. M. G. Martín, F. Pfrieger, and C. G. Dotti, “Cholesterol in Brain Disease: Sometimes Determinant and Frequently Implicated,” EMBO Reports 15, no. 10 (2014): 1036–1052, https://doi.org/10.15252/embr.201439225.

LinkOut - more resources